Patents Assigned to RECCE PHARMACEUTICALS LIMITED
  • Patent number: 10226482
    Abstract: A method of treatment of infection in a subject comprising administering to the subject a copolymer comprising an acrolein derived segment or a polyacrolein oligomer segment and a polyalkylene glycol oligomer segment, the copolymer having a molecular weight of no more than 1500 Daltons.
    Type: Grant
    Filed: November 17, 2015
    Date of Patent: March 12, 2019
    Assignee: RECCE PHARMACEUTICALS LIMITED
    Inventors: Graham John Hamilton Melrose, Michele Keryn Dilizia